Involvement of cytochrome b(5) in the metabolism of tetrachlorobiphenyls catalyzed by CYP2B1 and CYP1A1

被引:17
|
作者
Matsusue, K
Ariyoshi, N
Oguri, K
Koga, N
Yoshimura, H
机构
[1] KYUSHU UNIV 62,FAC PHARMACEUT SCI,HIGASHI KU,FUKUOKA 81282,JAPAN
[2] NAKAMURA GAKUEN UNIV,DEPT FOOD & NUTR,JOHNAN KU,FUKUOKA 81401,JAPAN
关键词
cytochrome b(5); cytochrome P450; tetrachlorobiphenyl (TCB); polychlorinated biphenyl (PCB); CYP2B1; CYP1A1;
D O I
10.1016/0045-6535(95)00318-5
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The role of cytochrome b(5) in the cytochrome P450 (CYP)-dependent hydroxylation of tetrachlorobiphenyl (TCB) isomers was examined using a reconstituted mixed function oxygenase (MFO) system containing purified CYP2B1 or 1A1, and rat liver microsomes. Hydroxylations of 2,2',5,5'- and 3,3',4,4'-TCBs were catalyzed mainly by CYP2B1 and 1A1, respectively, in the reconstituted MFO system and those of 2,3',4',5- and 2,3',4,4'-TCBs were mediated by both cytochrome P450 systems. The activity toward 2,2',5,5'- and 2,3',4',5-TCB was significantly increased 6.5- and 5.5-fold, respectively, by addition of cytochrome b, in the reconstituted MFO system containing of CY2B1. Either hydroxylation activity toward 2,3',4,4'-TCB with the CYP2B1 system was very low or decreased by addition of cytochrome b(5). These results suggest that the involvement of cytochrome b(5) to the hydroxylation of TCBs is dependent on the TCB congener being metabolized, and the cytochrome P450 isoform involved in its metabolism.
引用
收藏
页码:517 / 523
页数:7
相关论文
共 50 条
  • [21] Evaluation of herbicide metabolism in transgenic rice plants expressing CYP1A1 and CYP2B6
    Kawahigashi, H
    Hirose, S
    Ohkawa, H
    Ohkawa, Y
    NEW DISCOVERIES IN AGROCHEMICALS, 2005, 892 : 18 - 27
  • [22] Promoter region analysis of the rat CYP2B1 and CYP2B2 genes
    Sommer, KM
    Ramsden, R
    Sidhu, J
    Costa, P
    Omiecinski, CJ
    PHARMACOGENETICS, 1996, 6 (04): : 369 - 374
  • [23] Differential induction of mrna expression of cytochromes P450 (CYP2B1 and CYP1A1/2) by metyrapone in primary rat hepatocyte cultures
    Aubrecht, J
    HirschErnst, KI
    Foth, H
    Kahl, GF
    Hohne, MW
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1996, 94 (01) : 47 - 61
  • [24] Spurious observation of splenic CYP2B1 expression
    Sharma, MR
    Periandythevar, P
    Shapiro, BH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) : 1074 - 1076
  • [25] AGFD 66-Methylothiostilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities
    Mikstacka, Renata
    Baer-Dubowska, Wanda
    Wieczorek, Marcin
    Sobiak, Stanislaw
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 92 - 92
  • [26] Quantitative analysis of the Ah receptor/cytochrome P450CYP1B1/CYP1A1 signalling pathway
    McFadyen, MCE
    Rooney, PH
    Melvin, WT
    Murray, GI
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (10) : 1663 - 1674
  • [27] Regulatory sequence responsible for insulin destabilization of cytochrome P4502B1 (CYP2B1) mRNA
    Truong, NT
    Moncion, A
    Barouki, R
    Beaune, P
    de Waziers, I
    BIOCHEMICAL JOURNAL, 2005, 388 : 227 - 235
  • [28] Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5 and CYP2B1 by phenylimidazoles.
    Spatzenegger, M
    Wang, Q
    He, YQ
    Halpert, JR
    FASEB JOURNAL, 2000, 14 (08): : A1337 - A1337
  • [29] Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations
    Pragyan, Preeti
    Kesharwani, Siddharth S.
    Nandekar, Prajwal P.
    Rathod, Vijay
    Sangamwar, Abhay T.
    MOLECULAR DIVERSITY, 2014, 18 (04) : 865 - 878
  • [30] Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations
    Preeti Pragyan
    Siddharth S. Kesharwani
    Prajwal P. Nandekar
    Vijay Rathod
    Abhay T. Sangamwar
    Molecular Diversity, 2014, 18 : 865 - 878